Page last updated: 2024-12-11
furapromide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
furapromide: structure; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6433308 |
MeSH ID | M0051214 |
Synonyms (18)
Synonym |
---|
n-isopropyl-5-nitro-2-furanacrylamide |
n-isopropyl-3-(5-nitro-2-furyl)acrylamide |
2-furanacrylamide, n-isopropyl-5-nitro- |
n-(1-methylethyl)-3-(5-nitro-2-furanyl)-2-propenamide |
n-(isopropyl)-3-(5-nitro-2-furanyl)-2-propenamide |
s30066 , |
n-isopropyl-5-nitro-2-furylacrylamide |
furapromide |
furapromidium |
2-propenamide, n-(1-methylethyl)-3-(5-nitro-2-furanyl)- |
n-isopropyl-3-(5-nitro-2-furyl)-acrylamide |
ccris 1104 |
(e)-3-(5-nitrofuran-2-yl)-n-propan-2-ylprop-2-enamide |
1951-56-0 |
31365-44-3 |
n-ipr-3-(5-no2-2-furyl)acrylamide |
DTXSID30875965 |
(e)-n-isopropyl-3-(5-nitrofuran-2-yl)acrylamide |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |